Cardiovascular disease in chronic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

Cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD) is high, and the presence of CKD worsens outcomes of cardiovascular disease (CVD). CKD is associated with specific risk factors. Emerging evidence indicates that the pathology and manifestation of CVD differ in the...

Full description

Saved in:
Bibliographic Details
Main Authors: Herzog, Charles A. (Author) , Asinger, Richard W. (Author) , Berger, Alan K. (Author) , Charytan, David M. (Author) , Díez, Javier (Author) , Hart, Robert G. (Author) , Eckardt, Kai-Uwe (Author) , Kasiske, Bertram L. (Author) , McCullough, Peter A. (Author) , Passman, Rod S. (Author) , DeLoach, Stephanie S. (Author) , Pun, Patrick H. (Author) , Ritz, Eberhard (Author)
Format: Article (Journal)
Language:English
Published: [2 September 2011]
In: Kidney international
Year: 2011, Volume: 80, Issue: 6, Pages: 572-586
ISSN:1523-1755
DOI:10.1038/ki.2011.223
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/ki.2011.223
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0085253815551053
Get full text
Author Notes:Charles A. Herzog, Richard W. Asinger, Alan K. Berger, David M. Charytan, Javier Díez, Robert G. Hart, Kai-Uwe Eckardt, Bertram L. Kasiske, Peter A. McCullough, Rod S. Passman, Stephanie S. DeLoach, Patrick H. Pun, and Eberhard Ritz
Description
Summary:Cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD) is high, and the presence of CKD worsens outcomes of cardiovascular disease (CVD). CKD is associated with specific risk factors. Emerging evidence indicates that the pathology and manifestation of CVD differ in the presence of CKD. During a clinical update conference convened by the Kidney Disease: Improving Global Outcomes (KDIGO), an international group of experts defined the current state of knowledge and the implications for patient care in important topic areas, including coronary artery disease and myocardial infarction, congestive heart failure, cerebrovascular disease, atrial fibrillation, peripheral arterial disease, and sudden cardiac death. Although optimal strategies for prevention, diagnosis, and management of these complications likely should be modified in the presence of CKD, the evidence base for decision making is limited. Trials targeting CVD in patients with CKD have a large potential to improve outcomes.
Item Description:Gesehen am 22.09.2022
Physical Description:Online Resource
ISSN:1523-1755
DOI:10.1038/ki.2011.223